RESEARCH-USE BIOSIMILAR ANTIBODY
Tigatuzumab
Monoclonal antibody · IgG1
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-114
CATALOG NUMBERSC-BS-114
MOLECULAR WEIGHTApprox. 144.64 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
Tigatuzumab is a recombinant research-use antibody directed against TNFRSF10B.